- PARADIGM ™ program comprises two 12-week randomized, placebo-controlled studies (APPROACH and EMBRACE) and a long-term extension study (EXTEND) - - EXTEND: a Phase III Open Label Extension Study ...
Nursing instructor Mary Iverson liked to speak Spanish, to socialize, sew. Yet in her late 50s, Mary, wife of cardio-thoracic surgeon Leigh Iverson, and mother to their three daughters, noticed ...
SAN FRANCISCO, February 12, 2025--(BUSINESS WIRE)--Homeward ®, a company committed to rearchitecting the delivery of health and care in partnership with communities everywhere, starting in rural ...
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results